125 related articles for article (PubMed ID: 27475989)
21. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
[TBL] [Abstract][Full Text] [Related]
22. Involvement of mortalin in cellular senescence from the perspective of its mitochondrial import, chaperone, and oxidative stress management functions.
Yaguchi T; Aida S; Kaul SC; Wadhwa R
Ann N Y Acad Sci; 2007 Apr; 1100():306-11. PubMed ID: 17460192
[TBL] [Abstract][Full Text] [Related]
23. Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.
Avraham M; Sinkovits G; Hurler L; Prohászka Z; Fishelson Z
Front Immunol; 2024; 15():1337215. PubMed ID: 38715618
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells.
Qu M; Zhou Z; Chen C; Li M; Pei L; Yang J; Wang Y; Li L; Liu C; Zhang G; Yu Z; Wang D
Neurosci Res; 2012 Jan; 72(1):94-102. PubMed ID: 22001761
[TBL] [Abstract][Full Text] [Related]
25. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
Carney DF; Koski CL; Shin ML
J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
[TBL] [Abstract][Full Text] [Related]
26. [The effect of the membrane attack complex C5b-9 on liver cells during traumatic hemorrhagic shock in rat].
Zhao ZL; Cao SH; Wang YQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):158-61. PubMed ID: 21366945
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the nucleotide-binding domain of mortalin, the mitochondrial Hsp70 chaperone.
Amick J; Schlanger SE; Wachnowsky C; Moseng MA; Emerson CC; Dare M; Luo WI; Ithychanda SS; Nix JC; Cowan JA; Page RC; Misra S
Protein Sci; 2014 Jun; 23(6):833-42. PubMed ID: 24687350
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric segregation of mitochondria and mortalin correlates with the multi-lineage potential of inner ear sensory cell progenitors in vitro.
Rivolta MN; Holley MC
Brain Res Dev Brain Res; 2002 Jan; 133(1):49-56. PubMed ID: 11850063
[TBL] [Abstract][Full Text] [Related]
29. Critical Role of Mortalin/GRP75 in Endothelial Cell Dysfunction Associated with Acute Lung Injury.
Leonard A; Su PY; Yule DI; Rahman A; Fazal F
Shock; 2020 Aug; 54(2):245-255. PubMed ID: 31490354
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
32. Role of C5b-9 and RGC-32 in Cancer.
Vlaicu SI; Tatomir A; Rus V; Rus H
Front Immunol; 2019; 10():1054. PubMed ID: 31156630
[TBL] [Abstract][Full Text] [Related]
33. Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C.
Kraus S; Fishelson Z
Eur J Immunol; 2000 May; 30(5):1272-80. PubMed ID: 10820372
[TBL] [Abstract][Full Text] [Related]
34. Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells.
Qu M; Zhou Z; Xu S; Chen C; Yu Z; Wang D
Brain Res; 2011 Jan; 1368():336-45. PubMed ID: 20974113
[TBL] [Abstract][Full Text] [Related]
35. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N
Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931
[TBL] [Abstract][Full Text] [Related]
36. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.
Huang MB; Wu JY; Lillard J; Bond VC
Oncotarget; 2019 Sep; 10(52):5419-5438. PubMed ID: 31534628
[No Abstract] [Full Text] [Related]
37. Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines.
Gestl EE; Anne Böttger S
Biochem Biophys Res Commun; 2012 Jun; 423(2):411-6. PubMed ID: 22683628
[TBL] [Abstract][Full Text] [Related]
38. Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9.
Georgiannakis A; Burgoyne T; Lueck K; Futter C; Greenwood J; Moss SE
J Immunol; 2015 Oct; 195(7):3382-9. PubMed ID: 26324770
[TBL] [Abstract][Full Text] [Related]
39. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
40. Mortalin mutations are not a frequent cause of early-onset Parkinson disease.
Freimann K; Zschiedrich K; Brüggemann N; Grünewald A; Pawlack H; Hagenah J; Lohmann K; Klein C; Westenberger A
Neurobiol Aging; 2013 Nov; 34(11):2694.e19-20. PubMed ID: 23831374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
